摘要:最近在新奥尔良召开的美国心脏学会上公布的研究表明,SYNERGY试验显示,在快速介入性治疗的高危菲ST段抬高的急性冠脉综合征(ACS)病人中,安万特公司的低分子量肝素-依诺肝素(enoxaparin,Lovenox)与未分馏的肝素(UFH)等效,且依诺肝素可能与更多的出血相关。
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Journal of Systems Science and Systems Engineering Journal of Systems Science and Complexity Science China Chemistry Research in Astronomy and Astrophysics Chinese Physics C Journal of Systems Engineering and Electronics Plasma Science and Technology Chinese Physics B Journal of Energy Chemistry Journal of Systematics and Evolution Journal of Materials Science Technology Chinese Journal of Structural Chemistry相关文章
syb创业计划书